Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview: The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a gr... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryMarket Overview:The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028. Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe. Molecular Diagnostics Market Trends: Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users. Breakup by Product: Reagents and Kits Instruments Software and Services Breakup by Technology: Polymerase Chain Reactions (PCR) Hybridization DNA Sequencing Microarray Isothermal Nucleic Acid Amplification Technology (INAAT) Others Breakup by Application: Infectious Diseases Diagnostics Oncology Genetic Testing Blood Screening Others Breakup by End Users: Hospitals Laboratories Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific. Key Questions Answered in This Report: How has the global molecular diagnostics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global molecular diagnostics market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the technology? What is the breakup of the market based on the application? What is the breakup of the market based on the end users? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global molecular diagnostics market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Molecular Diagnostics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Reagents and Kits 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Software and Services 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Technology 7.1 Polymerase Chain Reactions (PCR) 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Hybridization 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 DNA Sequencing 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Microarray 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT) 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast 8 Market Breakup by Application 8.1 Infectious Diseases Diagnostics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Oncology 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Genetic Testing 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Blood Screening 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End Users 9.1 Hospitals 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Laboratories 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Others 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia-Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Abbott Laboratories 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Agilent Technologies Inc. 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 Financials 15.3.2.4 SWOT Analysis 15.3.3 Becton Dickinson and Company 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.3.3 Financials 15.3.3.4 SWOT Analysis 15.3.4 Biomerieux SA 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Danaher Corporation 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.3 Financials 15.3.5.4 SWOT Analysis 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.) 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG) 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 SWOT Analysis 15.3.8 Hologic Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.8.4 SWOT Analysis 15.3.9 Illumina Inc. 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.9.4 SWOT Analysis 15.3.10 Myriad Genetics Inc. 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.10.4 SWOT Analysis 15.3.11 Qiagen 15.3.11.1 Company Overview 15.3.11.2 Product Portfolio 15.3.11.3 Financials 15.3.11.4 SWOT Analysis 15.3.12 Quidel Corporation 15.3.12.1 Company Overview 15.3.12.2 Product Portfolio 15.3.12.3 Financials 15.3.12.4 SWOT Analysis 15.3.13 Thermo Fisher Scientific 15.3.13.1 Company Overview 15.3.13.2 Product Portfolio 15.3.13.3 Financials 15.3.13.4 SWOT Analysis List of Figures Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022 Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028 Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022 Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022 Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022 Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022 Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022 Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022 Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022 Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022 Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022 Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022 Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022 Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022 Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022 Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022 Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022 Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022 Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022 Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022 Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022 Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022 Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022 Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022 Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022 Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022 Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028 Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis List of Tables Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028 Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028 Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028 Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028 Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028 Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028 Table 7: Global: Molecular Diagnostics Market: Competitive Structure Table 8: Global: Molecular Diagnostics Market: Key Players
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IMARC Services Private Limited.社の医療分野での最新刊レポート
本レポートと同じKEY WORD(diagnostics)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|